Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB033 (Opicinumab) in relapsing forms of multiple sclerosis (SYNERGY)
NCT01864148Phase 2Completed
- Sponsor
- Biogen
- Start
- Aug 2013
- Primary completion
- Dec 2015
- Countries
- 12
01
Overview
A Phase 2 trial of opicinumab in multiple sclerosis (MS), sponsored by Biogen. Started Aug 2013; status: completed.
02
Drugs
opicinumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01864148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01864148.